A Study to Learn If RNA Vaccines (BNT162b1 and BNT162b2) Are Safe and Can Prevent COVID-19 in Healthy Participants
A Phase 1/2/3, Placebo-Controlled, Randomized, Observer-Blind,
Dose-Finding Study to Evaluate the Safety, Tolerability, Immunogenicity, and Efficacy of
SARS-CoV-2 RNA Vaccine Candidates Against COVID-19 in Healthy Individuals
Category & Conditions: Coronavirus Disease (COVID-19)
Medicine: PF-07302048 (BNT162)
ClinicalTrials.gov Identifier (NCT): NCT04368728
Protocol ID: C4591001
PrintDownloadOpen Plain Language Summary Result: Click here